|
|
|
|
| RLN047b | 非小细胞肺癌组织芯片，附病理分级、TNM和临床分期，6例/24点，替代T047a | | 点 数 | 24 | 例 数 | 6 | | 行 数 | 4 | 列 数 | 6 | | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
|
Malignant (IB) Malignant (IIA) Malignant (IIB) Malignant (IIIA) |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | Tumor Size | isBackUp |
| A1 | 1 | 55 | F | Lung | Squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant | LEFT(L23,9) | N |
| A2 | 2 | 64 | M | Lung | Squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant | LEFT(L24,9) | N |
| A3 | 3 | 71 | M | Lung | Adeocarcinoma | 2 | T2N1M0 | IIB | Malignant | LEFT(L25,9) | N |
| A4 | 4 | 55 | F | Lung | Squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant | LEFT(L26,9) | N |
| A5 | 5 | 64 | M | Lung | Squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant | LEFT(L27,9) | N |
| A6 | 6 | 71 | M | Lung | Adeocarcinoma | 2 | T2N1M0 | IIB | Malignant | LEFT(L28,9) | N |
| B1 | 7 | 70 | M | Lung | Adeocarcinoma | 2 | T3N1M0 | IIIA | Malignant | LEFT(L29,9) | N |
| B2 | 8 | 57 | F | Lung | Bronchioloalveolar carcinoma | * | T2aN1M0 | IIA | Malignant | LEFT(L30,9) | N |
| B3 | 9 | 39 | M | Lung | Large cell carcinoma | * | T2N0M0 | IB | Malignant | LEFT(L31,9) | N |
| B4 | 10 | 70 | M | Lung | Adeocarcinoma | 2 | T3N1M0 | IIIA | Malignant | LEFT(L32,9) | N |
| B5 | 11 | 57 | F | Lung | Bronchioloalveolar carcinoma | * | T2aN1M0 | IIA | Malignant | LEFT(L33,9) | N |
| B6 | 12 | 39 | M | Lung | Large cell carcinoma | * | T2N0M0 | IB | Malignant | LEFT(L34,9) | N |
| C1 | 13 | 55 | F | Lung | Squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant | LEFT(L35,9) | N |
| C2 | 14 | 64 | M | Lung | Squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant | LEFT(L36,9) | N |
| C3 | 15 | 71 | M | Lung | Adeocarcinoma | 2 | T2N1M0 | IIB | Malignant | LEFT(L37,9) | N |
| C4 | 16 | 55 | F | Lung | Squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant | LEFT(L38,9) | N |
| C5 | 17 | 64 | M | Lung | Squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant | LEFT(L39,9) | N |
| C6 | 18 | 71 | M | Lung | Adeocarcinoma | 2 | T2N1M0 | IIB | Malignant | LEFT(L40,9) | N |
| D1 | 19 | 70 | M | Lung | Adeocarcinoma | 2 | T3N1M0 | IIIA | Malignant | LEFT(L41,9) | N |
| D2 | 20 | 57 | F | Lung | Bronchioloalveolar carcinoma | * | T2aN1M0 | IIA | Malignant | LEFT(L42,9) | N |
| D3 | 21 | 39 | M | Lung | Large cell carcinoma | * | T2N0M0 | IB | Malignant | LEFT(L43,9) | N |
| D4 | 22 | 70 | M | Lung | Adeocarcinoma | 2 | T3N1M0 | IIIA | Malignant | LEFT(L44,9) | N |
| D5 | 23 | 57 | F | Lung | Bronchioloalveolar carcinoma | * | T2aN1M0 | IIA | Malignant | LEFT(L45,9) | N |
| D6 | 24 | 39 | M | Lung | Large cell carcinoma | * | T2N0M0 | IB | Malignant | LEFT(L46,9) | N |
| E1 | 25 | | | | | | | | | N |
|
|
